Osteoarthritis: The Multimodal Mindset
Osteoarthritis affects an estimated 60–80% of dogs over 8 years and 90%+ of cats over 12 years—yet feline OA remains dramatically underdiagnosed. This episode moves beyond NSAIDs into a complete systems approach: pain scoring tools you can implement tomorrow, anti-NGF monoclonal antibodies that represent a paradigm shift, and environmental modifications that cost nothing but change everything. Follow Luna, a 12-year-old cat whose owner thought she was 'just slowing down,' through a multimodal protocol that restores both mobility and quality of life.
Learning Objectives
- 1Explain the difference between OA pain mechanisms in dogs vs. cats and identify why feline OA is dramatically underdiagnosed
- 2Analyze the mechanism of action of monoclonal antibody anti-NGF therapies (Librela and Solensia) and how they differ from NSAIDs
- 3Build a complete multimodal OA protocol for a feline patient, including NSAID selection, environmental modifications, nutraceuticals, and integrative modalities
- 4Evaluate validated pain scoring tools—CBPI, LOAD, Feline Grimace Scale, Helsinki Chronic Pain Index—and apply them for treatment monitoring
- 5Identify appropriate environmental modifications and weight management strategies specific to osteoarthritic cats
Course Syllabus
- 15 minOpening Case: Meet LunaPreview
case-intro
- 210 minOA in Dogs and Cats: A Tale of Two Presentations
presentations
- 38 minPain Scoring Tools: Measuring What Matters
pain-scoring
- 412 minThe New Pharmacologic Landscape: Anti-NGF Monoclonal Antibodies
anti-ngf
- 512 minBuilding a Complete Multimodal Protocol
multimodal-protocol
- 68 minLuna at 3 Months: Case Resolution and Long-Term Management
case-resolution
Final Assessment
10 questions · Passing score: 70%
Complete all course modules to unlock the assessment. Upon passing, your CE certificate will be generated automatically.